chartexchange

NBTX
Nanobiotix S.A.
stockNASDAQADR

At CloseNov 18, 2026 3:59:57 PM EST
27.01USD-1.603%(-0.44)44,327
After-hoursNov 18, 2026 4:00:30 PM EST
26.90USD-0.407%(-0.11)
Loading…
Loading…
Healthcare
Biotechnology
HQ
Paris, Ile De France, France
Previous Close
$27.45
Beta
1.83
52-Week High
$57.14 2026-05-14
52-Week Low
$19.14 2025-11-26
SMA 50
$29.72
SMA 200
$34.41
Avg. Vol 10D
150,783
Avg. Vol 30D
139,840
Avg. Vol 90D
148,798
Relative Vol
0.32
41.73M
122.9600%
1,626
NBTX Profile

nanobiotix (euronext: nano / isin: fr0011341205) is a late clinical-stage nanomedicine company pioneering novel approaches for the treatment of cancer. the company's first-in-class, proprietary technology, nanoxray, enhances radiotherapy energy with a view to providing a new, more efficient treatment for cancer patients. nanoxray products are compatible with current radiotherapy treatments and are meant to treat potentially a wide variety of solid tumors including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, breast cancer, glioblastoma, etc., via multiple routes of administration. nbtxr3 is being evaluated in: soft tissue sarcoma (sts), head and neck cancers, prostate cancer, and liver cancers (primary and metastases). additionally, head and neck cancer and rectal cancer trials led by nanobiotix's taiwanese partner, pharmaengine, are underway in the asia pacific region. the company started a new preclinical research program in immuno-oncology with its lea

NBTX Performance
PeriodPriceDateChangeBeta
1W32.252026-11-12-15.92%2.141
1M21.082026-10-19+28.63%1.491
3M45.392026-08-19-40.26%1.502
6M46.202026-05-19-41.31%1.429
1Y21.662025-11-19+25.18%1.827
2Y3.782024-11-19+617.33%—
5Y9.272021-11-19+192.50%0.158
NBTX Stock Summary

Nanobiotix S.A. (NASDAQ:NBTX) stock price today is $27.12, and today's volume is 44,327. NBTX is down 1.220% today. The 30 day average volume is 139,840. NBTX market cap is $1.38B with 50.95M shares outstanding.